AR is targeted by anti-androgenic therapies used for the treatment of prostate cancer and in tumors cooperates with HOXB13 [20], a gene that when mutated causes predisposition to prostate cancer [21]. The gene discussed is HOXB13; the disease is prostate carcinoma.